Literature DB >> 12606534

Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.

David T Robles1, George S Eisenbarth, Natalie J M Dailey, Laurence B Peterson, Linda S Wicker.   

Abstract

Susceptibility to diabetes in humans and nonobese diabetic (NOD) mice is believed to arise from the combined effect of multiple genetic loci, resulting in immune-mediated destruction of the insulin-secreting beta-cells. Insulin autoantibodies (IAAs) are often present in humans for years, and in NOD mice for weeks, before the onset of diabetes. We have evaluated the expression of IAAs in NOD mice and in diabetes-resistant NOD congenic strains to characterize the association of autoantibody expression with insulitis and diabetes. In NOD congenic strains with genes that contribute to protection from insulitis and diabetes (Idd3, Idd5, Idd10, and Idd18), the prevalence of IAAs is reduced relative to NOD mice. In contrast, NOD.B10 Idd9 mice have a high prevalence of IAAs and a high degree of insulitis, despite a nearly complete resistance to diabetes. These data indicate that IAA expression is a phenotype that is associated with insulitis and correlates with overall disease progression in some strains of congenic mice but not in others. It is likely that patients with type 1 diabetes will also show non-major histocompatibility complex genetically determined variation in expression of autoantibodies and progression to diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606534     DOI: 10.2337/diabetes.52.3.882

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

Review 1.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

Review 2.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 3.  B cell depletion in autoimmune diabetes: insights from murine models.

Authors:  Jayne L Chamberlain; Kesley Attridge; Chun Jing Wang; Gemma A Ryan; Lucy Sk Walker
Journal:  Expert Opin Ther Targets       Date:  2011-03-03       Impact factor: 6.902

4.  Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes.

Authors:  Xiaotian Lin; Emma E Hamilton-Williams; Daniel B Rainbow; Kara M Hunter; Yang D Dai; Jocelyn Cheung; Laurence B Peterson; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

5.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells.

Authors:  Emma E Hamilton-Williams; S B Justin Wong; Xavier Martinez; Daniel B Rainbow; Kara M Hunter; Linda S Wicker; Linda A Sherman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

7.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

Authors:  Laurent Poirot; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

8.  Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.

Authors:  Hiroaki Moriyama; Norio Abiru; Johanna Paronen; Kamila Sikora; Edwin Liu; Dongmei Miao; Devasenan Devendra; Joshua Beilke; Roberto Gianani; Ron G Gill; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

9.  Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

Authors:  Julie Mangada; Todd Pearson; Michael A Brehm; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; David V Serreze; Aldo A Rossini; Dale L Greiner
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

Review 10.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.

Authors:  James A Pearson; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2015-09-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.